Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07445191) titled 'Efficacy of Triamcinolone-Lidocaine Mix in Trigger Points Injection of Masseter Muscle: Double-blinded, Randomized Controlled Trial' on Feb. 24.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Outcomes Assessor).

Primary Sponsor: Cairo University

Condition: TMJ Pain

Intervention: Drug: Saline Drug: Triamcinolone with lidocaine

Recruitment Status: Not recruiting

Phase: Phase 2/Phase 3

Date of First Enrollment: March 1, 2026

Target Sample Size: 30

To know more, visit https:/...